Amplia Therapeutics Ltd (ATX) - Total Liabilities

Latest as of September 2025: AU$1.61 Million AUD ≈ $1.14 Million USD

Based on the latest financial reports, Amplia Therapeutics Ltd (ATX) has total liabilities worth AU$1.61 Million AUD (≈ $1.14 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Amplia Therapeutics Ltd cash flow conversion to assess how effectively this company generates cash.

Amplia Therapeutics Ltd - Total Liabilities Trend (2010–2025)

This chart illustrates how Amplia Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Amplia Therapeutics Ltd (ATX) asset resilience to evaluate the company's liquid asset resilience ratio.

Amplia Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Amplia Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
DAEMO Engineering Co. Ltd KQ:317850	Korea	₩16.68 Billion
Archer Materials Limited F:38A	Germany	€752.16K
Akin Tekstil AS IS:ATEKS	Turkey	TL1.71 Billion
Cross Timbers Royalty Trust NYSE:CRT	USA	$1.49 Million
Southport Acquisition Corp NYSE:PORT	USA	$10.58 Million
Matsa Resources Ltd AU:MAT	Australia	AU$12.59 Million
Broadwind Energy Inc NASDAQ:BWEN	USA	$50.52 Million

Liability Composition Analysis (2010–2025)

This chart breaks down Amplia Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Amplia Therapeutics Ltd (ATX) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	28.17	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	22.76	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amplia Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amplia Therapeutics Ltd (2010–2025)

The table below shows the annual total liabilities of Amplia Therapeutics Ltd from 2010 to 2025.

Year	Total Liabilities	Change
2025-03-31	AU$1.91 Million ≈ $1.35 Million	-44.20%
2024-03-31	AU$3.43 Million ≈ $2.42 Million	+20.29%
2023-03-31	AU$2.85 Million ≈ $2.02 Million	+8.07%
2022-03-31	AU$2.64 Million ≈ $1.87 Million	+388.95%
2021-03-31	AU$539.13K ≈ $381.47K	+5.58%
2020-03-31	AU$510.62K ≈ $361.30K	-3.08%
2019-03-31	AU$526.86K ≈ $372.79K	+88.55%
2018-03-31	AU$279.42K ≈ $197.71K	-69.22%
2017-03-31	AU$907.87K ≈ $642.38K	-11.97%
2016-03-31	AU$1.03 Million ≈ $729.75K	+127.72%
2015-03-31	AU$452.90K ≈ $320.45K	+12.18%
2014-03-31	AU$403.73K ≈ $285.67K	+111.38%
2013-03-31	AU$191.00K ≈ $135.14K	-92.51%
2012-03-31	AU$2.55 Million ≈ $1.80 Million	+43.32%
2011-03-31	AU$1.78 Million ≈ $1.26 Million	-20.18%
2010-03-31	AU$2.23 Million ≈ $1.58 Million	--

About Amplia Therapeutics Ltd

AU:ATX Australia Biotechnology

Market Cap

$50.82 Million

AU$71.83 Million AUD

Market Cap Rank

#21825 Global

#789 in Australia

Share Price

AU$0.14

Change (1 day)

-6.67%

52-Week Range

AU$0.05 - AU$0.36

All Time High

AU$16.20